Astrocytoma, Grade II
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG) (NCT02924038) | Nicholas Butowski | 2017-04-03 |
| GliomaAI-Astro23: MRI-Based Detection of IDH Mutant Astrocytoma (Grade 2 and 3) (NCT07673666) | Deep Learning Institute of Radiological Sciences | 2017-03-14 |
| Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma (NCT02549833) | Jennie Taylor | 2016-10-17 |
| Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors (NCT01836549) | Pediatric Brain Tumor Consortium | 2013-03-01 |
Track Astrocytoma, Grade II automatically
Every clearance here is in the API, with alerts when new ones post.